rmi 12330a has been researched along with fluo-3 in 1 studies
| Studies (rmi 12330a) | Trials (rmi 12330a) | Recent Studies (post-2010) (rmi 12330a) | Studies (fluo-3) | Trials (fluo-3) | Recent Studies (post-2010) (fluo-3) |
|---|---|---|---|---|---|
| 141 | 0 | 24 | 759 | 1 | 108 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, KT; Huang, Y; Kwan, HY; Ma, Y; Tang, NL; Yao, X; Yu, S | 1 |
1 other study(ies) available for rmi 12330a and fluo-3
| Article | Year |
|---|---|
CNGA2 contributes to ATP-induced noncapacitative Ca2+ influx in vascular endothelial cells.
Topics: Adenine; Adenosine Diphosphate; Adenosine Triphosphate; Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Aminoquinolines; Aniline Compounds; Animals; Calcium Channel Blockers; Calcium Signaling; Cattle; Cells, Cultured; Cyclic GMP; Cyclic Nucleotide-Gated Cation Channels; Diltiazem; Endothelial Cells; Enzyme Inhibitors; Imines; Male; Mice; Mice, Inbred C57BL; Microscopy, Confocal; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Receptors, Purinergic P2Y1; RNA Interference; Thionucleotides; Time Factors; Transfection; Vasodilation; Xanthenes | 2010 |